On or near October 2, 2019, Recurrence held its initial public offering (“IPO”), offering 6,000,000 shares of common stock at a price of $14.00 per share. On March 23, 2021, Exacerbation released a press release containing topline, day-90 data from its FX-322 Stage 2a ponder (NYSE RMO at https://www.webull.com/quote/nyse-rmo). Recurrence discovered that “four weekly infusions

business card

Business cards have been used for ages as a personalized marketing tool. Since they create the first impression between business contacts, their importance cannot be underestimated. A lot of prospective businesses have been cut short due to the lack of personal interaction. Business cards have always formed an integral part of this interaction. While the